Grail (GRAL) News Today $17.42 +0.01 (+0.06%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Grail reports cash balance of $767M, sees runway into 2028January 16 at 4:40 PM | markets.businessinsider.comGrail up 4% to $18.84 after guidance in conference presentationJanuary 16 at 4:40 PM | markets.businessinsider.comGrail (NASDAQ:GRAL) Shares Down 4.4% - Time to Sell?Grail (NASDAQ:GRAL) Stock Price Down 4.4% - What's Next?January 16 at 2:23 PM | marketbeat.com94,178 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by 180 Wealth Advisors LLC180 Wealth Advisors LLC purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 94,178 shares of the company's stock, valued at approximatelyJanuary 14 at 8:05 AM | marketbeat.comPatient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet OncologyJanuary 14 at 4:35 AM | stockhouse.comGrail: Patient-reported outcomes from PATHFINDER study published in LancetJanuary 14 at 4:35 AM | msn.comPatient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet OncologyJanuary 13, 2025 | prnewswire.comFinancial Review: Enzo Biochem (NYSE:ENZ) & Grail (NASDAQ:GRAL)January 13, 2025 | americanbankingnews.comDouglas Lane & Associates LLC Buys New Shares in Grail, Inc. (NASDAQ:GRAL)Douglas Lane & Associates LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm purchased 169,977 shares of the company's stock, valued at approximately $3,034,000. Douglas Lane & AssociateJanuary 9, 2025 | marketbeat.comGrail (NASDAQ:GRAL) Stock Price Down 7.4% - Here's What HappenedGrail (NASDAQ:GRAL) Trading Down 7.4% - Here's What HappenedJanuary 7, 2025 | marketbeat.comGolden Grail Beverages announces change to UPDC Beverages dealJanuary 2, 2025 | msn.comGrail, Inc. (NASDAQ:GRAL) Short Interest UpdateGrail, Inc. (NASDAQ:GRAL - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 4,900,000 shares, an increase of 11.9% from the November 30th total of 4,380,000 shares. Currently, 17.0% of the company's stock are short sold. Based on an average daily trading volume, of 800,300 shares, the short-interest ratio is currently 6.1 days.December 30, 2024 | marketbeat.comGrail (NASDAQ:GRAL) Stock Price Down 6.7% - Here's What HappenedGrail (NASDAQ:GRAL) Shares Down 6.7% - What's Next?December 30, 2024 | marketbeat.comFate/strange Fake: A Holy Grail War Gone WrongDecember 27, 2024 | msn.comDisappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the companyDecember 25, 2024 | finance.yahoo.comGrail (NASDAQ:GRAL) Shares Gap Down - Here's WhyGrail (NASDAQ:GRAL) Shares Gap Down - Here's What HappenedDecember 20, 2024 | marketbeat.comGRAIL to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 18, 2024 | prnewswire.comGrail (NASDAQ:GRAL) Shares Down 11.1% - Here's WhyGrail (NASDAQ:GRAL) Trading Down 11.1% - Here's WhyDecember 18, 2024 | marketbeat.comGrail (NASDAQ:GRAL) Hits New 12-Month High - Here's WhyGrail (NASDAQ:GRAL) Reaches New 52-Week High - Time to Buy?December 16, 2024 | marketbeat.comGrail, Inc. (NASDAQ:GRAL) Short Interest Up 15.9% in NovemberGrail, Inc. (NASDAQ:GRAL - Get Free Report) saw a significant growth in short interest in November. As of November 30th, there was short interest totalling 4,380,000 shares, a growth of 15.9% from the November 15th total of 3,780,000 shares. Based on an average trading volume of 726,200 shares, the short-interest ratio is presently 6.0 days. Approximately 15.4% of the company's stock are short sold.December 16, 2024 | marketbeat.comGrail: Lack Of Near Term Catalyst; Market Likely To Lose Interest SoonDecember 16, 2024 | seekingalpha.comGRAIL: Biotech Stock Targeting $100B Cancer MarketGRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.December 14, 2024 | marketbeat.comCanyon Grail CF SL 7 AXS review: a gravel bike of two halves?December 8, 2024 | msn.comGrail (NASDAQ:GRAL) Sets New 1-Year High - Here's WhyGrail (NASDAQ:GRAL) Reaches New 1-Year High - Time to Buy?December 6, 2024 | marketbeat.comWorld's biggest hedge fund flags the ‘holy grail' that may shield investors if U.S. stock rally crumblesDecember 5, 2024 | marketwatch.comGRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)December 3, 2024 | prnewswire.comShort Interest in Grail, Inc. (NASDAQ:GRAL) Increases By 7.1%Grail, Inc. (NASDAQ:GRAL - Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,780,000 shares, an increase of 7.1% from the October 31st total of 3,530,000 shares. Approximately 14.4% of the shares of the company are sold short. Based on an average trading volume of 743,000 shares, the days-to-cover ratio is currently 5.1 days.December 3, 2024 | marketbeat.comMorgan Stanley Initiates Coverage of GRAIL (GRAL) with Equal-Weight RecommendationNovember 28, 2024 | msn.comGrail (NASDAQ:GRAL) Coverage Initiated by Analysts at Morgan StanleyMorgan Stanley started coverage on shares of Grail in a research note on Wednesday. They set an "equal weight" rating and a $16.00 price objective for the company.November 27, 2024 | marketbeat.comGRAIL, Inc.: GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer StudyNovember 20, 2024 | finanznachrichten.deGrail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin Sells 30,452 SharesNovember 20, 2024 | insidertrades.comGRAIL to Participate in Upcoming Investor ConferencesNovember 19, 2024 | prnewswire.comGrail tests first patient for TROPION-Lung12 Phase 3 studyNovember 19, 2024 | markets.businessinsider.comGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer StudyNovember 18, 2024 | prnewswire.comWolfe starts Grail at Peer Perform on time and money needsNovember 17, 2024 | markets.businessinsider.comGrail (NASDAQ:GRAL) Earns Peer Perform Rating from Analysts at Wolfe ResearchWolfe Research started coverage on shares of Grail in a research note on Friday. They issued a "peer perform" rating for the company.November 15, 2024 | marketbeat.comGRAIL Inc. (GRAL) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comGRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 14, 2024 | sg.finance.yahoo.comEXCLUSIVE: The Gemological Institute of America’s CEO Susan Jacques Talks Diamonds, Mining and Gem TrendsNovember 14, 2024 | yahoo.comGRAIL Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | prnewswire.comFilmmakers Who Landed Julia Roberts, George Clooney to Narrate Ads Speak Out on Provocative Spots That Riled ConservativesNovember 7, 2024 | msn.comGrail (GRAL) Set to Announce Quarterly Earnings on TuesdayGrail (NASDAQ:GRAL) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641766)November 5, 2024 | marketbeat.comGRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 4, 2024 | prnewswire.comHow Do You Make a Movie About the Vatican? With Divine InterventionOctober 31, 2024 | msn.comGRAIL to Announce Third Quarter 2024 Financial ResultsOctober 29, 2024 | prnewswire.comCharles Hoskinson calls Cardano the home of Bitcoin (BTC) after bridge launchOctober 26, 2024 | msn.comGRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer ConferenceOctober 23, 2024 | prnewswire.comGRAIL Appoints Sarah Krevans to Board of DirectorsOctober 21, 2024 | prnewswire.comRetail Media Networks: Present And FutureOctober 21, 2024 | forbes.comGuggenheim Initiates Coverage of GRAIL (GRAL) with Neutral RecommendationOctober 19, 2024 | msn.com Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address GRAL Media Mentions By Week GRAL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRAL News Sentiment▼0.300.72▲Average Medical News Sentiment GRAL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRAL Articles This Week▼105▲GRAL Articles Average Week Get Grail News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GeneDx News Ardent Health Partners News Addus HomeCare News PACS Group News Progyny News Teladoc Health News Fortrea News National HealthCare News Viridian Therapeutics News AdaptHealth News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRAL) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grail, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grail With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRAL Stock Alerts